You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API deflazacort oral

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing deflazacort oral

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
Tris Pharma Inc	deflazacort oral	27808-249	ACETIC ACID
Tris Pharma Inc	deflazacort oral	27808-249	BENZYL ALCOHOL
Tris Pharma Inc	deflazacort oral	27808-249	CARBOXYMETHYLCELLULOSE SODIUM
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for deflazacort oral

Excipient focus: ACETIC ACID

deflazacort oral drug variants containing ACETIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing ACETIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BENZYL ALCOHOL

deflazacort oral drug variants containing BENZYL ALCOHOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing BENZYL ALCOHOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

deflazacort oral drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM ALUMINUM SILICATE TYPE IIA

deflazacort oral drug variants containing MAGNESIUM ALUMINUM SILICATE TYPE IIA

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing MAGNESIUM ALUMINUM SILICATE TYPE IIA

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

deflazacort oral drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL SOLUTION

deflazacort oral drug variants containing SORBITOL SOLUTION

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing SORBITOL SOLUTION

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

deflazacort oral drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Tris Pharma Inc	deflazacort oral	27808-249
>Company	>Ingredient	>NDC

deflazacort oral drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.